Xuantai Pharmaceutical: Controlling shareholder Lianhe Investment voluntarily promises not to reduce its holdings of the company's shares within 2 years.

On the evening of August 17th, Xuantai Pharmaceuticals announced that, based on confidence in the company's future development prospects and recognition of the company's long-term value, as well as to enhance investor confidence, effectively protect investor rights and maintain the stability of the capital market, the company's controlling shareholder, Lianhe Investment, voluntarily pledged not to reduce its holdings of the company's shares through methods such as centralized bidding transactions and block transactions for a period of 24 months starting from August 25, 2025.